Every weight loss method eventually levels off. The physiology behind plateaus, why GLP-1 medications delay them, and how to tell a true plateau from ordinary fluctuation.
Weight loss is not a straight line, and it does not continue indefinitely. At some point the scale stops moving even though nothing obvious has changed. People experience this as failure or as the medication "wearing off," but a plateau is a predictable feature of how the body regulates weight, and understanding it changes how you respond to it. This article explains the physiology, what the GLP-1 trials show about timing, and how to tell a real plateau from the noise of week-to-week fluctuation. It is educational and not a substitute for discussing your own progress with a licensed provider.
The body defends its weight. When you eat less and lose weight, two things happen in response. Energy expenditure falls, partly because a smaller body costs less to run and partly because of an additional adaptive slowdown. And appetite rises, through hormonal signals that increase hunger and reduce fullness in proportion to the weight lost.
In a 2018 review in Medical Clinics of North America, Kevin Hall and Scott Kahan of the National Institutes of Health described these responses as a feedback control system. Each kilogram lost increases the drive to eat by a measurable amount, which they estimated at roughly 100 calories per day per kilogram in people restricting their diet. Over months, that rising appetite pressure meets the fixed effort of a diet, and intake creeps back up to match a now lower expenditure. The result is a plateau, typically within about 12 months of starting a diet, and often sooner because adherence also tends to fade.
A well-known study from the same NIH group followed contestants from a televised weight loss competition for six years. Their resting metabolic rate remained lower than predicted for their body size long after the competition, an effect the authors called persistent metabolic adaptation. The study is small and the circumstances extreme, but it illustrates that the body's response to weight loss is not brief.
This is where the medications are genuinely different from dieting. In a 2024 paper in the journal Obesity, Hall used a validated mathematical model of energy balance to simulate the average weight trajectories from the semaglutide and tirzepatide trials alongside diet studies and bariatric surgery. Diet restriction alone did not change the strength of the appetite feedback loop; it just pushed against it. Semaglutide, tirzepatide and gastric bypass all appeared to weaken the feedback loop by an estimated 40 to 70 percent.
The practical consequence, according to the model, is that the plateau arrives later and at a lower weight: around 24 months for the medications compared with around 12 months for diet alone. The trial data are consistent with this. In STEP 1, weight was still declining gently at week 68 on semaglutide. In SURMOUNT-1, the curves were flattening but had not fully leveled at week 72.
Two things follow. First, a plateau at 12 or 18 months on a GLP-1 medication is not a sign the medication has stopped working; it is the medication working as the model predicts, with the body's regulatory system eventually reaching a new equilibrium. Second, averages hide enormous individual variation. Some people plateau early at a modest loss, some continue well past two years. The model explicitly cannot predict individual trajectories.
Before concluding that progress has stopped, it helps to rule out ordinary fluctuation. Body weight varies by one to two kilograms day to day based on fluid, sodium, carbohydrate intake, bowel contents, menstrual cycle and the time of weighing. A single week without change means very little.
A more reliable approach:
When a plateau is real, several factors are often involved, and most are addressable:
Intake has quietly risen. As weight drops, the appetite loop pushes intake up, and on a GLP-1 medication the effect is muted but not absent. Many people also stop tracking after the first months. A week of honest logging often reveals the drift. Our calorie deficit calculator can help recalibrate.
Expenditure has dropped. A lighter body burns fewer calories, both at rest and during activity. The deficit that worked at your starting weight is smaller now. Our TDEE calculator can estimate your current requirement, which will be lower than it was.
Activity has declined. Fatigue during adjustment periods can lead to less incidental movement without you noticing.
Protein is low. Inadequate protein makes fullness harder to achieve and encourages muscle loss, which lowers expenditure further. Clinical guidance for people on antiobesity medications recommends monitoring protein intake throughout treatment.
Sleep and stress. Short sleep and chronic stress both shift appetite hormones in a direction that favors intake. These are often the least examined contributors.
Medication factors. Missed doses, incorrect storage, or problems with a compounded product's potency can all reduce the medication's effect. If you are using a compounded medication, which is not FDA-approved and not reviewed for consistency the way brand products are, this is a reasonable question to raise with your prescriber. Dose adjustment is also a possibility a prescriber may consider, but it is a clinical decision and not one to make on your own.
A plateau is not evidence that you have reached your body's "set point" in any fixed sense, nor is it evidence that further loss is impossible. It is evidence that intake and expenditure have come into balance at the current weight. Changing either side of that balance can restart progress. It is also not a reason to stop treatment abruptly; the trial data on discontinuation, covered in our article on ongoing weight management, show that stopping typically leads to regain.
Clinical guidelines generally consider a sustained loss of 5 to 10 percent of starting weight clinically meaningful, with larger losses associated with greater improvements in blood pressure, blood sugar, lipids, sleep apnea and joint symptoms. If you have reached a plateau after a loss in that range or beyond, the health benefits are already substantial and the main task becomes keeping them. Maintenance is its own skill, and it is where most of the long-term health value lives.
A plateau usually means intake and expenditure have come into balance at a new, lower weight. It is a predictable feature of weight regulation and not by itself a sign the medication has stopped working.
Weigh at the same time under the same conditions, look at weekly averages, and consider a plateau real only after three to four weeks with no downward trend. Track waist circumference too, since fat loss can continue while the scale is flat.
Dose adjustment is a clinical decision for your prescriber, not one to make on your own. Your provider can review intake, activity, sleep, adherence and labs first.
Stopping abruptly typically leads to regain in the trial data. A plateau is a good time to check in with your licensed provider about maintenance.
A plateau is a normal point to check in with your licensed provider. They can review your intake, activity, sleep, medication adherence and any lab results, and discuss whether any change to your treatment plan makes sense. This article is educational and does not determine whether any treatment is appropriate for you.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
Resistance training is the single most effective way to protect muscle and bone while losing weight. Here is what the guidelines recommend, what the research shows, and how to begin safely without a gym background.
Read articleLosing weight means losing some muscle along with fat. What the research says about how much, why it matters, and the two levers that protect lean mass: protein intake and resistance training.
Read articleWhen appetite drops, the quality of each meal matters more. A practical guide to protein, fiber, fluids and micronutrients while taking a GLP-1 medication, drawn from published clinical guidance.
Read article